CDC committee supports expanded criteria for PCV13 vaccine

02/27/2013 | AAFP News Now

The CDC's Advisory Committee on Immunization Practices voted to expand age recommendations for certain individuals for the 13-valent pneumococcal conjugate vaccine and to include the Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid vaccine for high-risk children in the Vaccines for Children program. The committee approved four new influenza vaccine formulations for the 2013-14 flu season, along with recommendations for timing and spacing of vaccinations.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID